{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T16:21:42Z","timestamp":1771518102499,"version":"3.50.1"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":398,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"vor","delay-in-days":19,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"University of Saskatchewan WCVM Companion Animal Health Fund","award":["1-401302-1135-80015-8000"],"award-info":[{"award-number":["1-401302-1135-80015-8000"]}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The pathophysiology of polyuria and polydipsia secondary to exogenous glucocorticoid excess is incompletely understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Investigate plasma AVP (pAVP) and serum CoP (sCoP) concentrations in healthy dogs before, during, and after abrupt discontinuation of a long-term course of orally administered prednisolone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Eight healthy neutered young adult research Beagles.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In our prospective longitudinal study, Beagles were treated with a placebo PO q24h for 15\u2009days (baseline), followed by a 35-day course of prednisolone (2.35-2.75\u2009mg\/kg PO q24h) and then abrupt discontinuation of prednisolone. Serial pAVP and sCoP concentrations, urine specific gravity (USG) and calculated plasma osmolality (pOsmcalculated) were determined during placebo and prednisolone administration, and up to 4\u2009weeks after prednisolone discontinuation. Paired plasma samples for pAVP measurement were obtained in EDTA tubes with (pAVPP800) and without (pAVPEDTA) a proprietary combination of protease, esterase, and dipeptidyl peptidase-IV inhibitors (BD Biosciences P800).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Mean pAVPP800 and sCoP concentrations were significantly lower at the end of the prednisolone course (25.8\u2009\u00b1\u20098.1 pg\/mL\u00a0and 166\u2009pg\/mL, range, 131-223) vs baseline (34.1\u2009\u00b1\u20095.4 pg\/mL and 243\u2009pg\/mL, range, 157-336; P\u2009=\u2009.02, P\u2009=\u2009.02, respectively). Correlations between pAVPP800 and sCoP (r\u2009=\u2009.77, P\u2009=\u2009.001) and pAVPP800 and USG (r\u2009=\u2009.61, P\u2009=\u2009.02) were positive, despite no correlation between pAVPP800 and pOsmcalculated, sCoP and pOsmcalculated, and sCoP and USG. On paired samples, mean pAVPEDTA was significantly lower (5.0\u2009\u00b1\u20092.5\u2009pg\/mL) than mean pAVPP800 (34.1\u2009\u00b1\u20095.4\u2009pg\/mL; P\u2009&amp;lt;\u2009.0001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Clinical Importance<\/jats:title>\n                    <jats:p>Orally administered prednisolone led to markedly decreased plasma AVP and serum CoP concentrations despite increased calculated plasma osmolality and stable systolic blood pressure.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jvim.17304","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T06:46:32Z","timestamp":1737355592000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Orally administered prednisolone decreases plasma arginine vasopressin and serum copeptin concentrations in healthy dogs"],"prefix":"10.1093","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8358-5101","authenticated-orcid":false,"given":"Mathieu Victor","family":"Paulin","sequence":"first","affiliation":[{"name":"Western College of Veterinary Medicine, University of Saskatchewan Department of Small Animal Clinical Sciences, , Saskatoon, Saskatchewan,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorsa","family":"Mehrabanpour","sequence":"additional","affiliation":[{"name":"Western College of Veterinary Medicine, University of Saskatchewan Department of Veterinary Biomedical Sciences, , Saskatoon, Saskatchewan,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suraj","family":"Unniappan","sequence":"additional","affiliation":[{"name":"Western College of Veterinary Medicine, University of Saskatchewan Department of Veterinary Biomedical Sciences, , Saskatoon, Saskatchewan,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth C. R.","family":"Snead","sequence":"additional","affiliation":[{"name":"Western College of Veterinary Medicine, University of Saskatchewan Department of Small Animal Clinical Sciences, , Saskatoon, Saskatchewan,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,1,1]]},"reference":[{"key":"2026020302401180200_jvim17304-bib-0001","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1748-5827.2011.01190.x","article-title":"Primary care veterinary usage of systemic glucocorticoids in cats and dogs in three UK practices","volume":"53","author":"O'Neill","year":"2012","journal-title":"J Small Anim Pract"},{"key":"2026020302401180200_jvim17304-bib-0002","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/qjmed\/93.2.105","article-title":"Use of oral corticosteroids in the United Kingdom","volume":"93","author":"van Staa","year":"2000","journal-title":"QJM"},{"key":"2026020302401180200_jvim17304-bib-0003","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1111\/jvim.15543","article-title":"Clinical characteristics, breed differences, and quality of life in North American dogs with acute steroid-responsive meningitis-arteritis","volume":"33","author":"Lau","year":"2019","journal-title":"J Vet Intern Med"},{"key":"2026020302401180200_jvim17304-bib-0004","first-page":"1","volume-title":"Canine and Feline Endocrinology","author":"Nelson","year":"2015","edition":"4th ed."},{"key":"2026020302401180200_jvim17304-bib-0005","first-page":"583","article-title":"Osmoregulation of systemic vasopressin release during long-term glucocorticoid excess: a study in dogs with hyperadrenocorticism","volume":"124","author":"Biewenga","year":"1991","journal-title":"Acta Endocrinol"},{"key":"2026020302401180200_jvim17304-bib-0006","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1677\/joe.0.1220041","article-title":"Feedback control of vasopressin and corticotrophin secretion in conscious dogs: effect of hypertonic saline","volume":"122","author":"Raff","year":"1989","journal-title":"J Endocrinol"},{"key":"2026020302401180200_jvim17304-bib-0007","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1111\/jvim.16250","article-title":"Effects of desmopressin acetate administration in healthy dogs receiving prednisolone","volume":"35","author":"Galati","year":"2021","journal-title":"J Vet Intern Med"},{"key":"2026020302401180200_jvim17304-bib-0008","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.tem.2007.11.001","article-title":"Copeptin: clinical use of a new biomarker","volume":"19","author":"Morgenthaler","year":"2008","journal-title":"Trends Endocrinol Metab"},{"key":"2026020302401180200_jvim17304-bib-0009","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11154-019-09509-9","article-title":"Vasopressin and copeptin in health and disease","volume":"20","author":"Christ-Crain","year":"2019","journal-title":"Rev Endocr Metab Disord"},{"key":"2026020302401180200_jvim17304-bib-0010","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.2460\/ajvr.74.9.1206","article-title":"Validation of a commercially available enzyme immunoassay for measurement of plasma antidiuretic hormone concentration in healthy dogs and assessment of plasma antidiuretic hormone concentration in dogs with congestive heart failure","volume":"74","author":"Scollan","year":"2013","journal-title":"Am J Vet Res"},{"key":"2026020302401180200_jvim17304-bib-0011","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1111\/jvim.16504","article-title":"Ondansetron in dogs with nausea associated with vestibular disease: a double-blinded, randomized placebo-controlled crossover study","volume":"36","author":"Henze","year":"2022","journal-title":"J Vet Intern Med"},{"key":"2026020302401180200_jvim17304-bib-0012","article-title":"BD\u2122 P800 Blood Collection System; c2024 [cited 2024 Nov 7]","author":"bdbiosciences.com [Internet]"},{"key":"2026020302401180200_jvim17304-bib-0013","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1210\/clinem\/dgac070","article-title":"Approach to the patient: \u201cutility of the copeptin assay\u201d","volume":"107","author":"Christ-Crain","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"2026020302401180200_jvim17304-bib-0014","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/295299a0","article-title":"Nucleotide sequence of cloned cDNA encoding bovine arginine vasopressin-neurophysin II precursor","volume":"295","author":"Land","year":"1982","journal-title":"Nature"},{"key":"2026020302401180200_jvim17304-bib-0015","article-title":"Investigation of serum copeptin concentrations in diabetic dogs [abstract]","author":"Springfield","year":"2023"},{"issue":"1","key":"2026020302401180200_jvim17304-bib-0016","first-page":"530","article-title":"Validation of a copeptin assay in normal dogs [abstract]","volume":"38","author":"Schermerhorn","year":"2024","journal-title":"J Vet Intern Med"},{"key":"2026020302401180200_jvim17304-bib-0017","first-page":"12","article-title":"Signs of anxiety and salivary copeptin levels in dogs diagnosed with separation-related problems in a short separation test","volume":"12","author":"Pierantoni","year":"2022","journal-title":"Animals (Basel)"},{"key":"2026020302401180200_jvim17304-bib-0018","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1939-1676.2007.tb03005.x","article-title":"Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats","volume":"21","author":"Brown","year":"2007","journal-title":"J Vet Intern Med"},{"key":"2026020302401180200_jvim17304-bib-0019","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1111\/jvim.15331","article-title":"ACVIM consensus statement: guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats","volume":"32","author":"Acierno","year":"2018","journal-title":"J Vet Intern Med"},{"key":"2026020302401180200_jvim17304-bib-0020","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/jvim.15463","article-title":"ACVIM consensus statement on the treatment of immune-mediated hemolytic anemia in dogs","volume":"33","author":"Swann","year":"2019","journal-title":"J Vet Intern Med"},{"key":"2026020302401180200_jvim17304-bib-0021","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.clinbiochem.2015.03.005","article-title":"Choice of the best equation for plasma osmolality calculation: comparison of fourteen formulae","volume":"48","author":"Martin-Calderon","year":"2015","journal-title":"Clin Biochem"},{"key":"2026020302401180200_jvim17304-bib-0022","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.clinbiochem.2016.06.001","article-title":"Basic concepts and practical equations on osmolality: biochemical approach","volume":"49","author":"Rasouli","year":"2016","journal-title":"Clin Biochem"},{"key":"2026020302401180200_jvim17304-bib-0023","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1161\/01.RES.46.1.58","article-title":"Evidence and quantification of the vasopressin arterial pressure control system in the dog","volume":"46","author":"Cowley","year":"1980","journal-title":"Circ Res"},{"key":"2026020302401180200_jvim17304-bib-0024","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1172\/JCI108377","article-title":"Distribution, blood transport, and degradation of antidiuretic hormone in man","volume":"57","author":"Baumann","year":"1976","journal-title":"J Clin Invest"},{"key":"2026020302401180200_jvim17304-bib-0025","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1152\/ajplegacy.1962.203.6.1179","article-title":"Rate of disappearance of arginine vasopressin from circulating blood in the dog","volume":"203","author":"Share","year":"1962","journal-title":"Am J Physiol"},{"key":"2026020302401180200_jvim17304-bib-0026","volume-title":"StatPearls [Internet]","author":"Koshy","year":"2022"},{"key":"2026020302401180200_jvim17304-bib-0027","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1210\/jc.2010-2499","article-title":"Correlation of plasma copeptin and vasopressin concentrations in hypo-, iso-, and hyperosmolar states","volume":"96","author":"Balanescu","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2026020302401180200_jvim17304-bib-0028","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1530\/eje.1.02299","article-title":"Effect of exogenous glucocorticoid on osmotically stimulated antidiuretic hormone secretion and on water reabsorption in man","volume":"155","author":"Bahr","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"2026020302401180200_jvim17304-bib-0029","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.pcl.2018.09.006","article-title":"Nephrogenic diabetes insipidus","volume":"66","author":"Kavanagh","year":"2019","journal-title":"Pediatr Clin North Am"},{"key":"2026020302401180200_jvim17304-bib-0030","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1530\/EJE-10-0030","article-title":"Direct effect of methylprednisolone on renal sodium and water transport via the principal cells in the kidney","volume":"162","author":"Lauridsen","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"2026020302401180200_jvim17304-bib-0031","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1210\/jcem-67-2-348","article-title":"Plasma levels of atrial natriuretic hormone in Cushing's syndrome","volume":"67","author":"Yamaji","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"2026020302401180200_jvim17304-bib-0032","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.2460\/ajvr.1991.52.11.1831","article-title":"Atrial natriuretic peptide concentration in dogs with congestive heart failure, chronic renal failure, and hyperadrenocorticism","volume":"52","author":"Vollmar","year":"1991","journal-title":"Am J Vet Res"},{"key":"2026020302401180200_jvim17304-bib-0033","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/B978-1-4557-4456-5.00014-6","volume-title":"Canine and Feline Endocrinology","author":"Reusch","year":"2015","edition":"4th ed."},{"key":"2026020302401180200_jvim17304-bib-0034","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1740-8261.2011.01884.x","article-title":"Effect of glucocorticoid administration on adrenal gland size and sonographic appearance in beagle dogs","volume":"53","author":"Pey","year":"2012","journal-title":"Vet Radiol Ultrasound"},{"key":"2026020302401180200_jvim17304-bib-0035","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/305325a0","article-title":"Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin","volume":"305","author":"Rivier","year":"1983","journal-title":"Nature"},{"key":"2026020302401180200_jvim17304-bib-0036","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/299355a0","article-title":"Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin","volume":"299","author":"Gillies","year":"1982","journal-title":"Nature"},{"key":"2026020302401180200_jvim17304-bib-0037","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0195-5616(01)50001-7","article-title":"Polyuria and polydipsia. Diagnostic approach and problems associated with patient evaluation","volume":"31","author":"Nichols","year":"2001","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"2026020302401180200_jvim17304-bib-0038","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1373\/clinchem.2005.060038","article-title":"Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin","volume":"52","author":"Morgenthaler","year":"2006","journal-title":"Clin Chem"},{"key":"2026020302401180200_jvim17304-bib-0039","doi-asserted-by":"crossref","first-page":"10104","DOI":"10.1038\/s41598-021-89505-9","article-title":"Validity of different copeptin assays in the differential diagnosis of the polyuria-polydipsia syndrome","volume":"11","author":"Sailer","year":"2021","journal-title":"Sci Rep"},{"key":"2026020302401180200_jvim17304-bib-0040","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/vcp.12006","article-title":"ASVCP reference interval guidelines: determination of de novo reference intervals in veterinary species and other related topics","volume":"41","author":"Friedrichs","year":"2012","journal-title":"Vet Clin Pathol"},{"key":"2026020302401180200_jvim17304-bib-0041","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1939-165X.2012.00414.x","article-title":"Subject-based reference values: biological variation, individuality, and reference change values","volume":"41","author":"Walton","year":"2012","journal-title":"Vet Clin Pathol"},{"key":"2026020302401180200_jvim17304-bib-0042","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1161\/CIRCULATIONAHA.106.685503","article-title":"C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study","volume":"115","author":"Khan","year":"2007","journal-title":"Circulation"},{"key":"2026020302401180200_jvim17304-bib-0043","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2362.2007.01762.x","article-title":"Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections","volume":"37","author":"Muller","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"2026020302401180200_jvim17304-bib-0044","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1210\/jc.2006-2046","article-title":"Anterior and posterior pituitary function testing with simultaneous insulin tolerance test and a novel copeptin assay","volume":"92","author":"Katan","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2026020302401180200_jvim17304-bib-0045","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1210\/jc.2017-01891","article-title":"Release and decay kinetics of copeptin vs AVP in response to osmotic alterations in healthy volunteers","volume":"103","author":"Fenske","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2026020302401180200_jvim17304-bib-0046","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1172\/JCI107423","article-title":"Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma","volume":"52","author":"Robertson","year":"1973","journal-title":"J Clin Invest"},{"key":"2026020302401180200_jvim17304-bib-0047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.domaniend.2004.01.007","article-title":"Pulsatile secretion pattern of vasopressin under basal conditions, after water deprivation, and during osmotic stimulation in dogs","volume":"27","author":"van Vonderen","year":"2004","journal-title":"Domest Anim Endocrinol"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/39\/1\/jvim17304\/66651801\/jvim17304.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/39\/1\/jvim17304\/66651801\/jvim17304.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T07:40:24Z","timestamp":1770104424000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/doi\/10.1111\/jvim.17304\/8422587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jvim.17304","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,1]]},"published":{"date-parts":[[2025,1,1]]},"assertion":[{"value":"2024-08-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"jvim17304"}}